Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Sara Beatriz Monteiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.
 

The initiative aims to strengthen health literacy through accessible, educational content based on the best available scientific evidence.

Developed through a partnership between the Champalimaud Foundation and the Faculdade de Medicina da Universidade de Lisboa (FMUL), the programme supports the career development of surgeons and clinician-scientists committed to advancing cancer research. The PhD degree is granted by FMUL within the framework of the Lisbon Academic Medical Centre PhD Programme.

Tuesday 16 June 2026

21:00 

The Doctors’ Lounges are spaces where medicine continues beyond medical consultations and treatment rooms at the Champalimaud Foundation.

Here, doctors gather to review cases, exchange perspectives, update medical records, catch up on their reading and think together. 

It’s a place designed for concentration and care, where knowledge is constantly refined and expanded through everyday clinical practice.

It allows quiet moments to question and combine experience with research and study.

The award recognises initiatives with a significant environmental, social and governance impact within the Portuguese market. Other nominees in this category included EDP, with the project Moonshot Next Best Action, Fundação MEO, with Música com Sentido, and NOS, with the project 5G enabler de uma indústria mais eficiente, developed in partnership with Sumol Compal.

Redefining brain and mental health care through neurotechnologies – from Alzheimer’s to stroke, from Obsessive Compulsive Disorder to depression –, is the declared goal of the new Digital Neurotherapeutics Centre (DNTx), which opened its doors to the public at the Champalimaud Foundation (CF) on May 18th.

To know more about this research:

The Champalimaud Foundation today announced the acquisition of a portfolio of T-cell receptor (TCR) programs, platform technologies, and associated assets from Medigene Immunotherapies GmbH, together with the execution of an exclusive license agreement with Helmholtz Munich for key chimeric co-stimulatory receptor technologies.

Host

Miguel Seabra, PhD, Ocular low-cost gene therapy

Venue

Seminar Room